Skip to main content
Log in

Modeling correlates of low bone mineral density in patients with phenylalanine hydroxylase deficiency

  • Original Article
  • Published:
Journal of Inherited Metabolic Disease

Abstract

Phenylalanine hydroxylase (PAH) deficiency is an inherited metabolic disorder requiring life-long restriction of dietary protein and phenylalanine-free medical food. Low bone mineral density (BMD) is reported, but factors associated with BMD Z-score (standard deviations from normal) are unknown. We examined associations between clinical and dietary parameters and total BMD Z-score in PAH deficiency patients, and developed models to predict Z-score. Data collected from patients >4 years of age (n = 88; mean age = 18.8 y; 61 % female) included demographic, clinical, laboratory, and dietary intakes. Adjusted Spearman’s correlation coefficients were calculated between parameters and TBMD Z-score, measured by dual energy x-ray absorptiometry (DXA). Parameters approaching significance (p-value < 0.10) were candidate predictors for four linear regression models predicting TBMD Z-score. To validate, model-predicted Z-scores were compared to DXA Z-scores. Mean TBMD Z-score was −0.326; 18 (20.4 %) had Z-score < −1. Z-scores were positively correlated with dietary vitamin D, calcium, and medical food intake and compliance with prescription, and negatively with dietary carbohydrate, sugar, caffeine intake, glycemic load, and prescribed medical food (grams protein/day; p-value < 0.05). The best model included medical food compliance, medical food intake, caffeine intake, and bone-specific alkaline phosphatase (r-square = 0.364). This model predicted Z-score category [normal or low (<−1)] with sensitivity = 66.7 %, likelihood ratio = 14.7, and AUC = 0.83 compared to DXA Z-score. No subjects had low BMD for chronological age (Z-score ≤ −2). Compliance with medical food prescription was the strongest predictor of TBMD Z-score. One model, if validated in a separate sample of patients with more cases of low BMD, showed potential to estimate TBMD Z-score using routine clinical patient parameters.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • ABIM. (2012, 05/2012). Bone density tests. Choosing Wisely Retrieved July 13 2015, 2015, from http://www.choosingwisely.org/patient-resources/bone-density-tests/

  • Bellazzi R, Zupan B (2008) Predictive data mining in clinical medicine: current issues and guidelines. Int J Med Inform 77(2):81–97

  • Bergmann P, Body JJ, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, Kaufman JM, Reginster JY, Gangji V, M. Members of Advisory Board on Bone (2009) Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club. Int J Clin Pract 63(1):19–26

  • Bhupathiraju SN, Tobias DK, Malik VS, Pan A, Hruby A, Manson JE, Willett WC, Hu FB (2014) Glycemic index, glycemic load, and risk of type 2 diabetes: results from 3 large US cohorts and an updated meta-analysis. Am J Clin Nutr 100(1):218–232

  • Camp KM, Parisi MA, Acosta PB, Berry GT, Bilder DA, Blau N, Bodamer OA, Brosco JP, Brown CS, Burlina AB, Burton BK, Chang CS, Coates PM, Cunningham AC, Dobrowolski SF, Ferguson JH, Franklin TD, Frazier DM, Grange DK, Greene CL, Groft SC, Harding CO, Howell RR, Huntington KL, Hyatt-Knorr HD, Jevaji IP, Levy HL, Lichter-Konecki U, Lindegren ML, Lloyd-Puryear MA, Matalon K, MacDonald A, McPheeters ML, Mitchell JJ, Mofidi S, Moseley KD, Mueller CM, Mulberg AE, Nerurkar LS, Ogata BN, Pariser AR, Prasad S, Pridjian G, Rasmussen SA, Reddy UM, Rohr FJ, Singh RH, Sirrs SM, Stremer SE, Tagle DA, Thompson SM, Urv TK, Utz JR, van Spronsen F, Vockley J, Waisbren SE, Weglicki LS, White DA, Whitley CB, Wilfond BS, Yannicelli S, Young JM (2014) Phenylketonuria scientific review conference: state of the science and future research needs. Mol Genet Metab 112(2):87–122

  • Cederbaum S (2002) Phenylketonuria: An update. Curr Opin Pediatr 14(6):702–706

  • de Groot MJ, Hoeksma M, van Rijn M, Slart RH, van Spronsen FJ (2012) Relationships between lumbar bone mineral density and biochemical parameters in phenylketonuria patients. Mol Genet Metab 105(4):566–570

  • Demirdas S, Coakley KE, Bisschop PH, Hollak CE, Bosch AM, Singh RH (2015) Bone health in phenylketonuria: a systematic review and meta-analysis. Orphanet J Rare Dis 10(1):17

  • Demirkol M, Gizewska M, Giovannini M, Walter J (2011) Follow up of phenylketonuria patients. Mol Genet Metab 104(Suppl):S31–S39

  • Di Daniele N, Carbonelli MG, Candeloro N, Iacopino L, De Lorenzo A, Andreoli A (2004) Effect of supplementation of calcium and vitamin D on bone mineral density and bone mineral content in peri- and post-menopause women; a double-blind, randomized, controlled trial. Pharmacol Res 50(6):637–641

  • Efendic S, Cerasi E, Luft R (1971) Role of glucose in arginine-induced insulin release in man. Metabolism 20(6):568–579

  • El Maghraoui A, Roux C (2008) DXA scanning in clinical practice. QJM 101(8):605–617

  • Frank MP, Powers RW (2007) Simple and rapid quantitative high-performance liquid chromatographic analysis of plasma amino acids. J Chromatogr B Analyt Technol Biomed Life Sci 852(1–2):646–649

  • Garcia-Hernandez A, Arzate H, Gil-Chavarria I, Rojo R, Moreno-Fierros L (2012) High glucose concentrations alter the biomineralization process in human osteoblastic cells. Bone 50(1):276–288

  • Goran MI, Driscoll P, Johnson R, Nagy TR, Hunter G (1996) Cross-calibration of body-composition techniques against dual-energy X-ray absorptiometry in young children. Am J Clin Nutr 63(3):299–305

  • Harding CO (2010) New era in treatment for phenylketonuria: pharmacologic therapy with sapropterin dihydrochloride. Biologics 4:231–236

  • Harnack L, Stevens M, Van Heel N, Schakel S, Dwyer JT, Himes J (2008) A computer-based approach for assessing dietary supplement use in conjunction with dietary recalls. J Food Compost Anal 21(Suppliment 1):S78–S82

  • Hernandez-Avila M, Stampfer MJ, Ravnikar VA, Willett WC, Schiff I, Francis M, Longcope C, McKinlay SM, Longscope C (1993) Caffeine and other predictors of bone density among pre- and perimenopausal women. Epidemiology 4(2):128–134

  • ISCD. (2007, January 4, 2013). Skeletal Health Assessment In Children and Adolescents (Males and Females ages 5–19). 2007 ISCD Official Positions 2007. Retrieved December 20, 2013, 2013, from http://www.iscd.org/official-positions/2007-iscd-official-positions-pediatric/

  • ISCD. (2013, August 15, 2013). 2013 ISCD Official Positions - Adult. 2013 ISCD Official Positions 2013. Retrieved December 20, 2013, 2013, from http://www.iscd.org/official-positions/2013-iscd-official-positions-adult/

  • Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ III, Khaltaev N (2008) A reference standard for the description of osteoporosis. Bone 42(3):467–475

  • Kanis JA, Oden A, Johansson H, Borgstrom F, Strom O, McCloskey E (2009) FRAX and its applications to clinical practice. Bone 44(5):734–743

  • Koura HM, Abdallah Ismail N, Kamel AF, Ahmed AM, Saad-Hussein A, Effat LK (2011) A long-term study of bone mineral density in patients with phenylketonuria under diet therapy. Arch Med Sci 7(3):493–500

  • Leib ES, Lewiecki EM, Binkley N, Hamdy RC (2004) Official positions of the international society for clinical densitometry. South Med J 97(1):107–110

  • Lloyd T, Rollings NJ, Kieselhorst K, Eggli DF, Mauger E (1998) Dietary caffeine intake is not correlated with adolescent bone gain. J Am Coll Nutr 17(5):454–457

    Article  CAS  PubMed  Google Scholar 

  • Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312(7041):1254–1259

  • Miras A, Boveda MD, Leis MR, Mera A, Aldamiz-Echevarria L, Fernandez-Lorenzo JR, Fraga JM, Couce ML (2013) Risk factors for developing mineral bone disease in phenylketonuric patients. Mol Genet Metab 108(3):149–154

  • Modan-Moses D, Vered I, Schwartz G, Anikster Y, Abraham S, Segev R, Efrati O (2007) Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis 30(2):202–208

  • NBS Connect Patient Registry (2014) Phenylketonuria Registry Data. Accessed from https://nbs.patientcrossroads.org/

  • Newsholme P, Bender K, Kiely A, Brennan L (2007) Amino acid metabolism, insulin secretion and diabetes. Biochem Soc Trans 35(Pt 5):1180–1186

  • Perez-Duenas B, Cambra FJ, Vilaseca MA, Lambruschini N, Campistol J, Camacho JA (2002) New approach to osteopenia in phenylketonuric patients. Acta Paediatr 91(8):899–904

  • Pietrobelli A, Faith MS, Allison DB, Gallagher D, Chiumello G, Heymsfield SB (1998) Body mass index as a measure of adiposity among children and adolescents: a validation study. J Pediatr 132(2):204–210

  • Przyrembel H, Bremer HJ (2000) Nutrition, physical growth, and bone density in treated phenylketonuria. Eur J Pediatr 159(Suppl 2):S129–S135

  • Quirk ME, Dobrowolski SF, Nelson BE, Coffee B, Singh RH (2012) Utility of phenylalanine hydroxylase genotype for tetrahydrobiopterin responsiveness classification in patients with phenylketonuria. Mol Genet Metab 107(1–2):31–36

  • Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL (2001) Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr 74(5):694–700

  • Rocha JC, van Spronsen FJ, Almeida MF, Soares G, Quelhas D, Ramos E, Guimaraes JT, Borges N (2012) Dietary treatment in phenylketonuria does not lead to increased risk of obesity or metabolic syndrome. Mol Genet Metab 107(4):659–663

  • Singh RH, Rohr F, Frazier D, Cunningham A, Mofidi S, Ogata B, Splett PL, Moseley K, Huntington K, Acosta PB, Vockley J, Van Calcar SC (2014) Recommendations for the nutrition management of phenylalanine hydroxylase deficiency. Genet Med 16(2):121–131

  • Stewart RM, Hemli S, Kolodny EH, Miller AL, Pallotta JA (1980) Carbohydrate metabolism in phenylketonuria. Pediatr Res 14(7):849–853

  • van Kuijk C (2010) Pediatric bone densitometry. Radiol Clin North Am 48(3):623–627

  • Vockley J, Andersson HC, Antshel KM, Braverman NE, Burton BK, Frazier DM, Mitchell J, Smith WE, Thompson BH, Berry SA, G. American College of Medical and C. Genomics Therapeutics (2014) Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med 16(2):188–200

  • Williams RA, Mamotte CD, Burnett JR (2008) Phenylketonuria: an inborn error of phenylalanine metabolism. Clin Biochem Rev 29(1):31–41

  • Winzenberg T, Jones G (2011) Dual energy X-ray absorptiometry. Aust Fam Physician 40(1–2):43–44

  • Zeman J, Bayer M, Stepan J (1999) Bone mineral density in patients with phenylketonuria. Acta Paediatr 88(12):1348–1351

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kathryn E. Coakley.

Ethics declarations

Conflict of interest

Rani H Singh has participated in and/or received research funding for clinical trials related to PAH deficiency. Rani H Singh confirms independence from the sponsors; the content of the article has not been influenced by the sponsors.

Kathryn E Coakley, Teresa D Douglas, Usha Ramakrishnan and Michael Goodman declare that they have no conflict of interest.

Informed consent

All procedures were in accordance with the ethical standards of the responsible committee on human experimentation (Emory Institutional Review Board and national) and with the Helsinki Declaration of 1975, as revised in 2000.

Informed consent was obtained from all patients for being included in the study.

Animal rights

This article does not contain any studies with animal subjects performed by any of the authors.

Additional information

Communicated by: Nenad Blau

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOCX 29 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Coakley, K.E., Douglas, T.D., Goodman, M. et al. Modeling correlates of low bone mineral density in patients with phenylalanine hydroxylase deficiency. J Inherit Metab Dis 39, 363–372 (2016). https://doi.org/10.1007/s10545-015-9910-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-015-9910-0

Navigation